Hepatitis Monthly

Published by: Kowsar

Plasma Zinc Level in Hepatitis C Patients With or Without Beta Thalassemia Major; Is There Any Difference?

Mohammad Abbasinazari 1 , * , Bita Behnava 2 , Yunes Panahi 3 , Azita Hajhossein Talasaz 4 , Shima Salimi 2 , Maryam Keshvari 5 , Leila Mehrnoush 2 , Pegah karimi Elizee 6 , Mohammad Gholami Fesharaki 2 , Mansour Asgharinia 1 and Seyed Moayed Alavian 2 , 6
Authors Information
1 Department of Clinical Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
3 Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
4 Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, IR Iran
5 Iranian Blood Transfusion Organization Reaserch Center, Tehran, IR Iran
6 Middle East Liver Disease, Tehran, IR Iran
Article information
  • Hepatitis Monthly: August 01, 2013, 13 (8); e11138
  • Published Online: August 12, 2013
  • Article Type: Brief Report
  • Received: March 10, 2013
  • Revised: June 18, 2013
  • Accepted: July 22, 2013
  • DOI: 10.5812/hepatmon.11138

To Cite: Abbasinazari M, Behnava B, Panahi Y, Hajhossein Talasaz A, Salimi S, et al. Plasma Zinc Level in Hepatitis C Patients With or Without Beta Thalassemia Major; Is There Any Difference?, Hepat Mon. 2013 ; 13(8):e11138. doi: 10.5812/hepatmon.11138.

Copyright © 2013, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Chasapis CT, Loutsidou AC, Spiliopoulou CA, Stefanidou ME. Zinc and human health: an update. Arch Toxicol. 2012; 86(4): 521-34[DOI][PubMed]
  • 2. Matsuoka S, Matsumura H, Nakamura H, Oshiro S, Arakawa Y, Hayashi J, et al. Zinc supplementation improves the outcome of chronic hepatitis C and liver cirrhosis. J Clin Biochem Nutr. 2009; 45(3): 292-303[DOI][PubMed]
  • 3. Abbasi Nazari M, Hasani Malayeri S, Pourhoseingholi MA, Mohebi SR, Zali MR. Evaluation of zinc plasma level in Iranian cirrhotic patients due to hepatitis B and hepatitis C. Hepat Mon. 2010; 10(1): 62-4
  • 4. Moriyama M, Matsumura H, Fukushima A, Ohkido K, Arakawa Y, Nirei K, et al. Clinical significance of evaluation of serum zinc concentrations in C-viral chronic liver disease. Dig Dis Sci. 2006; 51(11): 1967-77[DOI][PubMed]
  • 5. Himoto T, Hosomi N, Nakai S, Deguchi A, Kinekawa F, Matsuki M, et al. Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease. Scand J Gastroenterol. 2007; 42(9): 1078-87[DOI][PubMed]
  • 6. Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, et al. Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol Oncol. 2007; 29(4): 233-8[DOI][PubMed]
  • 7. Ataei B, Hashemipour M, Kassaian N, Hassannejad R, Nokhodian Z, Adibi P. Prevalence of anti HCV infection in patients with Beta-thalassemia in isfahan-iran. Int J Prev Med. 2012; 3-23[PubMed]
  • 8. Namazee N, Sali S, Asadi S, Shafiei M, Behnava B, Alavian SM. Real response to therapy in chronic hepatitis C virus patients: a study from iran. Hepat Mon. 2012; 12(9)[DOI][PubMed]
  • 9. Mahyar A, Ayazi P, Pahlevan AA, Mojabi H, Sehhat MR, Javadi A. Zinc and copper status in children with Beta-thalassemia major. Iran J Pediatr. 2010; 20(3): 297-302[PubMed]
  • 10. Mehdizadeh M, Zamani G, Tabatabaee S. Zinc status in patients with major beta-thalassemia. Pediatr Hematol Oncol. 2008; 25(1): 49-54[DOI][PubMed]
  • 11. Jacobes DS, Demott WR, Oxely DK. Leboratory test handbook. 2001; : 1169
  • 12. Yuasa K, Naganuma A, Sato K, Ikeda M, Kato N, Takagi H, et al. Zinc is a negative regulator of hepatitis C virus RNA replication. Liver Int. 2006; 26(9): 1111-8[DOI][PubMed]
  • 13. Grungreiff K, Reinhold D. Zinc: A complementary factor in the treatment of chronic hepatitis C? (Review). Mol Med Rep. 2010; 3(3): 371-5[DOI][PubMed]
  • 14. Kalkan A, Bulut V, Avci S, Celik I, Bingol NK. Trace elements in viral hepatitis. J Trace Elem Med Biol. 2002; 16(4): 227-30[DOI][PubMed]
  • 15. Arcasoy A, Cavdar AO. Changes of trace minerals (serum iron, zinc, copper and magnesium) in thalassemia. Acta Haematol. 1975; 53(6): 341-6[PubMed]
  • 16. Farzin L, Moassesi ME, Sajadi F, Amiri M, Shams H. Serum levels of antioxidants (Zn, Cu, Se) in healthy volunteers living in Tehran. Biol Trace Elem Res. 2009; 129(1-3): 36-45[DOI][PubMed]
  • 17. Grungreiff K, Hebell T, Gutensohn K, Reinhold A, Reinhold D. Plasma concentrations of zinc, copper, interleukin-6 and interferon-gamma, and plasma dipeptidyl peptidase IV activity in chronic hepatitis C. Mol Med Rep. 2009; 2(1): 63-8[DOI][PubMed]
  • 18. Tavajjoh M, Yasrebi J, Karimian N, Olama V. Phytic Acid Concentration and Phytic Acid: Zinc Molar Ratio in Wheat Cultivars and Bread Flours, Fars Province, Iran. J Agric Sci Tech. 2011; 13(5): 743-55
  • 19. Dabbaghmanesh MH, Taheri Boshrooyeh H, Kalantarhormozi MR, Ranjbar Omrani GH. Assessment of zinc concentration in random samples of the adult population in shiraz, iran. Iran Red Crescent Med J. 2011; 13(4): 249-55[PubMed]
  • 20. Jalali MT, Dayer D, Haghighizadeh MH, Karandish M. Very high prevalence of zinc deficiency in elderly hospitalized patients in Ahvaz, Iran. Saudi Med J. 2011; 32(3): 314-5[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments